Lactonova Nutripharm is a leading pharmaceutical contract manufacturing and nutraceutical company based in India. Established in 2005, Lactonova prides itself on being a diverse, global healthcare company with a focus on developing and manufacturing nutritional supplements supported by solid scientific evidence. With a track record of more than 15 years, the company offers a range of over 50 products and is actively working on the development of an additional 40 products. They have tailored product lines designed to address specific health conditions including metabolic syndrome, cardiovascular health, and fitness and performance. Lactonova is dedicated to being at the forefront of the industry, striving to become one of the fastest-growing companies in their sector. Their strategy involves a strong focus on Nutraceutical R&D and strategic partnerships with high-quality marketing and sales companies. As of now, there is no publicly available information regarding their last investment or the identity of the last investment investors. Lactonova's commitment to innovation and scientific excellence positions them as a noteworthy player in the pharmaceutical and nutraceutical space.
There is no investment information
No recent news or press coverage available for Lactonova Nutripharm.